Latest Biosimilar Stories
LONDON, April 6, 2015 /PRNewswire/ -- Report DetailsMedicine sales in Brazil - your guide to trends, opportunities and revenue prospectsDo you want to assess Brazil's pharmaceutical
LONDON, April 2, 2015 /PRNewswire/ -- Biosimilar drug producers - your guide to those companies' activities and prospects What does the future hold for makers of biosimilar
THOUSAND OAKS, Calif., March 30, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Goldman Sachs Key Debates in Biosimilars conference at 9:05 a.m.
-- Subsequent entry biologic (SEB) medicine provides a lower-cost, high-quality, safe and effective therapy for rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA)
-- Data presented at the National Kidney Foundation (NKF) Spring Meeting; single and multiple-dose pharmacokinetic and pharmacodynamic (PK/PD) studies support biosimilar application for Epoetin Hospira
With FDA's Approval of the First Biosimilar in the U.S., Groups Urge OMB to Work with FDA to Finalize Critical Naming Policy Supporting Patient Safety WASHINGTON, March 26, 2015 /PRNewswire-USNewswire/
According to the new report from BCC Research, the global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a
MANNHEIM, Germany, March 23, 2015 /PRNewswire-iReach/ -- The Biosimilars Group offers as a new and unique service to its clients - a one-day workshop for full biosimilar development project
Timely survey released as FDA approves first biosimilar WASHINGTON, March 23, 2015 /PRNewswire/ -- The Alliance for Safe
In a March 31 webinar, three veteran pharmacy observers will detail steps payers can take now to develop effective biosimilars management strategies. Washington,
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.